OBJECTIVE: We attempted to measure the prevalence of Parkinson's disease (PD) and to improve PD diagnosis in Lower Aragon (LA), a rural area located in northeast Spain with an elderly population numbering 60,724. METHODS: Hospital records and a questionnaire targeted at general practitioners and re
Treatment of Parkinson's disease in Spain
β Scribed by Francisco Grandas; Jaime Kulisevsky
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 46 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
To assess the patterns of drug use in Parkinson's disease in Spain, information about the clinical characteristics and current treatment of 1,803 parkinsonian patients was obtained from a nationwide survey, involving 241 physicians with practice based on the different assistance levels of the Spanish National Healthcare System. Approximately 90% of the patients were treated with levodopa, regardless of the characteristics of their physicians, but the use of the other available antiparkinsonian treatments was highly influenced by the medical specialty and interest in movement disorders of the prescribing doctors. Β© 2002 Movement Disorder Society
π SIMILAR VOLUMES
Deep brain stimulation (DBS) is a neurosurgical treatment of Parkinson's disease that is applied to three targets: the ventral intermediate nucleus of the thalamus (Vim), the globus pallidus internas (GPi) and the subthalamic nucleus (STN). Vim DBS mainly improves contralateral tremor and, therefore
## Abstract We measured the burden caused by Parkinson's disease (PD) in Spain during the year 2000 and compared it against PD burden worldwide and in the European A subregion. Burden of disease (BoD) is an important factor in health policy. Disabilityβadjusted life years (DALY) as a measure of BoD